Volume recovery offset by margin compression; profitability slides
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Maintained prior sub-15% EBITDA guide; achieved Q2 revenue growth as expected. Missed on profitability (PAT -6.9% YoY).
Cautiously Optimistic
next 1–2 quarters
Neutral
multi-year
Finolex's Q2 volume recovery (28% YoY) is real but masked by margin compression: PAT fell 6.9% YoY despite 27% revenue growth. Management maintained sub-15% EBITDA guidance but is relying on schemes and product-mix shifts to defend margins against raw-material volatility. Key risk: profitability gains are deferred to H2 and dependent on PVC pricing stabilization, which remains uncertain.
₹1094 Cr
Revenue · +27.4% YoY₹115 Cr
Reported PAT · −6.9% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Sales volume grew 28% YoY to 83,407 metric tons
METRevenue grew 27.4% YoY to ₹1,094 Cr; Q2 volume growth corroborates claim
Profitability remained flatish despite volume growth
OVERSTATEDPAT ₹115 Cr vs ₹123.4 Cr prior year (-6.9% YoY); PBT ₹153 Cr vs ₹158 Cr (-3.2%)
Sub-15% EBITDA margin for FY27 remains on track
METQ2 PBT margin ~14%, H1 PBT ~300 Cr on ₹1,978 Cr revenue (~15%); achievable but tight
Volume recovery driven by destocking channel recovery from Q1
METH1 volume 151,106 MT vs 157,465 MT prior year (-4% YoY); Q2's 28% offset Q1 weakness
Margin pressure due to high-cost Q1 inventory, not structural decline
PartialSchemes, discounts, product mix shift to non-agri offsetting price increases; structural dependency
Earnings quality
What changed since the last call
Volume growth materializes
UpgradeQ2 volume +28% YoY vs Q1 weakness; destocking recovery from channel as flagged in prior call
Profitability guidance tightened
NeutralSub-15% EBITDA maintained but tested by margin compression (Q2 ~14% PBT margin vs 15-16% historically)
Capex timing deferred
NeutralBoard yet to decide on INR150 Cr capex deployment; no FY28 capacity timeline given
Margin outlook hedged
DowngradeReliance on schemes/mix shifts to defend margins; no structural pricing-power improvements signaled
The Q&A
Analysts pressed hard on margin compression (Sneha, Tarreja; Shravan, Dolat): why does volume +28% not translate to earnings growth? Management acknowledged inventory lag from Q1 and scheme dependency but did not concede structural margin loss. On capex and cash deployment, management deferred entirely to Board—lack of visibility prompted repeated follow-ups (Ritesh, Investec). Overall tone was cautious despite optimistic framing.
Margin compression despite volume growth — Sneha, Tarreja
AnsweredQ1 inventory at higher PVC prices consumed in Q2; creates a time lag in realization. Also, schemes and discounts running in market to remain competitive, offsetting price gains.
Product mix & realization — Shravan Shah, Dolat Capital
PartialQ2 agri/non-agri 60-40; fitting 7-8% of volume. Non-agri growth offsetting some agri margin, but offsetting via better realization on larger non-agri volumes.
H1 volume decline despite Q2 recovery — Shravan Shah, Dolat Capital
PartialQ1 weakness from Q2 FY26 volume and channel destocking; Q2 recovery from destocking completion. October was good. H2 traditionally strong (Jan-May period). No quantified FY27 growth guidance given.
Capex and cash deployment — Ritesh Shah, Investec
DodgedBoard decision pending on form/shape of capex deployment. Debottlenecking exercises underway; higher-capacity extruder to replace lower-capacity units. Timing deferred; no firm timeline given.
Land monetization and cash use — Ritesh Shah, Investec
DodgedThree-year-old Board direction on monetization; no near-term decision yet. Board will take call on timing. Dividends already paid; shareholder reward ongoing but no special distributions planned.
El Niño and agri demand impact — Nirav, GeeCee
AnsweredEl Niño impact not fully realized yet; expected from November onwards. Tractor bookings and 2-wheeler bookings remain elevated (14-15%, 2-wheeler higher)—mixed signals. Margin on farmer income also a constraint but offset by input demand.
Capacity and utilization — Ritesh Shah, Investec
AnsweredTotal capacity 520 kt (pipe 425 kt, fitting 95 kt). Overall utilization ~67-70%. Sufficient headroom for current year and next. Capacity addition from debottlenecking underway.
Supply chain and sourcing — Pankaj, Kotak Neo
AnsweredMiddle East situation impacting all crude-oil downstream industries. Teams have re-established supply chains from alternative sources. EDC, VCM 100% imported into India; no direct domestic sourcing.
PVC pricing and tariff risk — Ritesh Shah, Investec
AnsweredAwaiting Ministry of Finance decision. CVD only on China region; MIP for all countries. If CVD implemented, may replace MIP. Outcome uncertain. Case strength is debatable.
PVC/EDC/VCM spot pricing — Ritesh Shah, Investec
AnsweredPVC ₹771/MT, PVC/EDC delta $455 on international market. EDC $450-500, VCM $900-950, ethylene $1,200-1,150. Prices elevated; availability tight due to geopolitical issues.
Guidance
FY27 revenue growth to be driven by Q2 recovery continuation
MediumNo quantified FY27 revenue target given. H1 +4% YoY; Q2 strong recovery but H2 hinges on PVC stabilization
Sub-15% EBITDA margin for FY27 maintained
MediumQ2 PBT margin ~14%, H1 ~15%; achievable but tight. Dependent on H2 realization and PVC pricing normalization; scheme reliance ongoing
INR150 Cr capex planned for FY27 (mostly debottlenecking)
LowBoard yet to finalize form/shape; timing deferred. Includes higher-capacity extruder replacement and routine maintenance. No clear timeline for capex deployment decisions
Risks the call surfaced
Raw material cost volatility
HighPVC prices, EDC, VCM, ethylene 100% imported. Q2 margin compression from Q1 high-cost inventory. Scheme reliance to offset pricing power loss.
Channel destocking sustainability
MediumQ2 28% volume growth from destocking recovery, not organic demand growth. H1 volume still -4% YoY. Risk: H2 normalization if destocking completes.
Geopolitical supply-chain disruption
MediumMiddle East tensions impacting petrochemical sourcing, shipping rates. EDC/VCM 100% imported; no domestic alternative. Risk: supply tightness, cost escalation.
Agri demand headwinds
MediumEl Niño, water scarcity, state relief programs constraining farmer income; agri is 60% of volume. Risk: volume decline in H2 if farm incomes weaken.
Capex timing indecision
LowBoard has not finalized capex deployment form/timing. INR150 Cr planned but no end-use clarity or timeline. Risk: delayed capacity addition, lost growth opportunity.
Management
Score 6/10. Decent transparency on operational metrics (volume, mix, utilization, pricing). Evasive on capex timing and land monetization. Acknowledged headwinds (inventory lag, scheme reliance) but framed cautiously optimistic despite PAT decline. Hit Q2 revenue growth target (+27.4% YoY). Missed on profitability (PAT -6.9% YoY). Maintained prior EBITDA margin guidance but tightened bandwidth. Capex deferral suggests limited conviction on timing.
1 · H2 FY27
PVC price stabilization; channel normalization post-destocking
2 · Q3 FY27
Test of volume sustainability; margin realization from lower input costs
3 · Q4/FY28
Capex commissioning (INR150 Cr planned); capacity addition debottlenecking benefits
Key risk: profitability gains are deferred to H2 and dependent on PVC pricing stabilization, which remains uncertain.
Informational and educational content only. Not investment advice.